• 1
    Mullin GE, Dobs A. Invited review. Vitamin D and its role in cancer and immunity. A prescription for sunlight. Nutr Clin Pract. 2007;22:305322.
  • 2
    Marx SJ. Vitamin D and other calciferols. In: ScriverCR, BeaudetAL, SlyWS, ValleD, eds. The Metabolic and Molecular Bases of Inherited Disease, Vol. 2, 7th edn. New York: McGraw-Hill; 1995:31033104.
  • 3
    Kramer B, Kanof A. VIII. Requirements. B. Of human beings. Sebrell JrWH, HarrisRS, eds. The Vitamins. Chemistry, Physiology, Pathology, Vol. II. New York: Academic Pres; 1954:257266.
  • 4
    Hathcock JN, Shao A, Vieth R, Heaney R. Risk assessment for vitamin D. Am J Clin Nutr. 2007;85:618.
  • 5
    Mellanby E. An experimental investigation on rickets. Lancet. 1919;1:407412.
  • 6
    McCollum EV, Simmons N, Pitz W. The relation of the unidentified dietary factors, the fat-soluble A and water-soluble B of the diet to the growth promoting properties of milk. J Biol Chem. 1916;27:3338.
  • 7
    McCollum EV, Simmonds N, Becker JE, Shipley PG. An experimental demonstration of the existence of a vitamin which promotes calcium deposition. J Biol Chem. 1922;53:293298.
  • 8
    Huldshinsky K. Heilung von rachitis durch kunstlich hohen-sonne. Deut Med Wochenschr. 1919;45:712713.
  • 9
    Steenbock H. Black fat-soluble vitamins. XVII. The induction of growth-promoting and calcifying properties in a ration by exposure to ultraviolet light. J Biol Chem. 1924;61:405422.
  • 10
    Hess AF, Weinstock M. Antirachitic properties imparted to lettuce and to growing wheat by ultraviolet irradiation. Proc Soc Exp Biol Med. 1924;22:56.
  • 11
    Holick MF, MacLaughlin JA, Clark MB, et al. Photosynthesis of previtamin D3 in human skin and the physiologic consequences. Science. 1980;210:203205.
  • 12
    Kodicek E. The metabolism of vitamin D. In: UmbreitW, MolitorH, eds. Proceedings of the Fourth International Congress of Biochemistry, Vol. 11. London: Pergamon; 1960:198208.
  • 13
    Haussler MR, Norman AW. The subcelluar distribution of physiological doses of vitamin D3. Arch Biochem Biophys. 1967;118:145153.
  • 14
    Morii H, Lund J, Neville PF, DeLuca HF. Biological activity of a vitamin D metabolite. Arch Biochem Biophys. 1967;120:508512.
  • 15
    Blunt JW, DeLuca HF, Schnoes HK. 25-Hydroxycholecalciferol. A biologically active metabolite of vitamin D3. Biochemistry. 1968;7:33173322.
  • 16
    Holick MF, Schnoes HK, DeLuca HF, Suda T, Cousins RJ. Isolation and identification of 1,25-dihydroxycholecalciferol. A metabolite of vitamin D active in intestine. Biochemistry. 1971;10:27992804.
  • 17
    Semmler EJ, Holick F, Schnoes HK, DeLuca HF. The synthesis of 1α,25-dihydroxycholecalciferol – a metabolically active form of vitamin D3. Tetrahedron Lett. 1972;40:41474150.
  • 18
    Holick MF, Semmler EJ, Schnoes HK, DeLuca HF. 1α-Hydroxy derivative of vitamin D3: a highly potent analog of 1α,25-dihydroxyvitamin D3. Science. 1973;180:190191.
  • 19
    DeLuca HF. Vitamin D: the vitamin and the hormone. Fed Proc. 1974;33:22112219.
  • 20
    Prader A, Illig R, Heierli E. Eine besondere form der primaren vitamin D-resistenten rachitis mit hypocalcamie und autosomal-dominantem erbgang: die hereditare pseudo-mangelrachitis. Helv Paediat Acta. 1961;16:452468.
  • 21
    Fraser D, Kooh SW, Kind HP, Holick MF, Tanaka Y, DeLuca HF. Pathogenesis of hereditary vitamin D dependent rickets: an inborn error of vitamin D metabolism involving defective conversion of 25-hydroxyvitamin D to 1α,25-dihydroxyvitamin D. N Engl J Med. 1973;289:817822.
  • 22
    Tucker G III, Gagnon RE, Haussler MR. Vitamin D3-25-hydroxylase: tissue occurrence and apparent lack of regulation. Arch Biochem Biophys. 1973;155:4757.
  • 23
    Ponchon G, DeLuca HF. The role of the liver in the metabolism of vitamin D. J Clin Invest. 1969;48:12731279.
  • 24
    Guo YD, Strugnell S, Black DW, Jones G. Transfected human liver cytochrome P-450 hydroxylates vitamin D analogs at different side-chain positions. Proc Natl Acad Sci USA. 1993;90:86688671.
  • 25
    Rosen H, Reshef A, Maeda N, et al. Markedly reduced bile acid synthesis but maintained level of cholesterol and vitamin D metabolites in mice with disrupted sterol 25-hyroxylase gene. J Biol Chem. 1998;273:1480514812.
  • 26
    Madhok TC, DeLuca HF. Characteristics of the rat liver microsomal enzyme system converting cholecalciferol into 25-hydroxycholecalciferol. Evidence of the participation of cytochrome P-450. Biochem J. 1979;184:491499.
  • 27
    Cheng JB, Motola DL, Mangelsdorf DJ, Russell DW. De-orphanization of cytochrome P450 2R1: a microsomal vitamin D 25-hydroxylase. J Biol Chem. 2003;278:3808438093.
  • 28
    Bhattacharyya MH, DeLuca HF. The regulation of the rat liver calciferol-25-hydroxylase. J Biol Chem. 1973;248:29692973.
  • 29
    Heaney RP, Davies KM, Chen TC, Holick MF, Barger-Lux MJ. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr. 2003;77:204210.
  • 30
    DeLuca HF, Schnoes HK, Vitamin D. Recent advances. Annu Rev Biochem. 1983;52:411439.
  • 31
    Brommage R, Jarnagin K, DeLuca HF, Yamada S, Takayama H. 1- But not 24-hydroxylation of vitamin D is required for skeletal mineralization in rats. Am J Physiol. 1983;244:E298E304.
  • 32
    Jarnagin K, Brommage R, DeLuca HF, Yamada S, Takayama H. 1- But not 24-hydroxylation of vitamin D is required for growth and reproduction in rats. Am J Physiol. 1983;244:E290E297.
  • 33
    Panda DK, Miao D, Tremblay ML, et al. Targeted ablation of the 25-hydroxyvitamin D 1α-hydroxylase enzyme: evidence for skeletal, reproductive, and immune dysfunction. Proc Natl Acad Sci USA. 2001;98:74987503.
  • 34
    Dardenne O, Prud'homme J, Arabian A, Glorieux FH, St-Arnaud R. Targeted inactivation of the 25-hydroxyvitamin D3-1α-hydroxylase gene (CYP27B1) creates an animal model of pseudovitamin D-deficiency rickets. Endocrinology. 2001;142:31353141.
  • 35
    Vanhooke JL, Prahl JM, Kimmel-Jehan C, et al. CYP27B1 null mice with LacZ reporter gene display no 25-hydroxyvitamin D3-1α-hydroxylase promoter activity in the skin. Proc Natl Acad Sci USA. 2006;103:7580.
  • 36
    Kitanaka S, Takeyama K, Murayama A, et al. Inactivating mutations in the 25-hydroxyvitamin D3 1α-hydroxylase gene in patients with pseudovitamin D-deficiency rickets. N Engl J Med. 1998;338:653661.
  • 37
    Hewison M, Adams JS. Extra-renal 1α-hydroxylase activity and human disease. Chapter 79. In: FeldmanD, PikeJW, GlorieuxFH, eds. Vitamin D, 2nd edn. San Diego, CA: Elsevier Academic Press; 2005:13801400.
  • 38
    Barbour GL, Coburn JW, Slatopolsky E, Norman AW, Horst RL. Hypercalcemia in an anephric patient with sarcoidosis. N Engl J Med. 1981;305:440443.
  • 39
    Reeve L, Tanaka Y, DeLuca HF. Studies on the site of 1,25-dihydroxyvitamin D3 synthesis in vivo. J Biol Chem. 1983;258:36153617.
  • 40
    Shultz TD, Fox J, Heath H 3rd, Kumar R. Do tissues other than the kidney produce 1,25-dihydroxyvitamnin D3 in vivo? A reexamination. Proc Natl Acad Sci USA. 1983;80:17461750.
  • 41
    Underwood JL, DeLuca HF. Vitamin D is not directly necessary for bone growth and mineralization. Am J Physiol. 1983;244:E493E498.
  • 42
    DeLuca HF, ed. Vitamin D. Metabolism and function. In: DeLucaHF, ed. Monographs on Endocrinology. Berlin: Springer-Verlag; 1979:180.
  • 43
    Garabedian M, Tanaka Y, Holick MF, DeLuca HF. Response of intestinal calcium transport and bone calcium mobilization to 1,25-dihydroxyvitamin D3 in thyroparathyroidectomized rats. Endocrinology. 1974;94:10221027.
  • 44
    Yamamoto M, Kawanoke Y, Takahashi H, Shimazawa E, Kimura S, Ogata E. Vitamin D deficiency and renal calcium transport in the rat. J Clin Invest. 1984;74:507553.
  • 45
    Jones G, Strugnell SA, DeLuca HF. Current understanding of the molecular actions of vitamin D. Physiol Rev. 1998;78:11931231.
  • 46
    Silver J, Naveh-Many T. Vitamin D and the parathyroids. In: FeldmanD, PikeJW, GlorieuxFH, eds. Vitamin D, 2nd edn. San Diego, CA: Elsevier Academic Press; 2005:537549.
  • 47
    Darwish HM, DeLuca HF. Identification of a transcription factor that binds to the promoter region of the human parathyroid hormone gene. Arch Biochem Biophys. 1999;365:123130.
  • 48
    Demay MB, Kiernan MS, DeLuca HF, Kronenberg HM. Sequences in the human parathyroid hormone gene that bind the 1,25-dhydroxyvitamin D3 receptor and mediate transcriptional repression in response to 1,25-dihydroxyvitamin D3. Proc Natl Acad Sci USA. 1992;89:80978101.
  • 49
    Chambers TJ, Magnus CJ. Calcitonin alters behaviour of isolated osteoclasts. J Pathol. 1982;136:2739.
  • 50
    Shinki T, Ueno Y, DeLuca HF, Suda T. Calcitonin is a major regulator of the expression of renal 25-hyroxyvitamin D3-1α-hydroxylase gene in normocalcemic rats. Proc Natl Acad Sci USA. 1999;96:82538258.
  • 51
    Brenza HL, Kimmel-Jehan C, Jehan F, et al. Parathyroid hormone activation of the 25-hydroxyvtaimin D3-1α-hydroxylase gene promoter. Proc Natl Acad Sci USA. 1998;95:13871391.
  • 52
    Holick MF, Schnoes HK, DeLuca HF, Gray RW, Boyle IT, Suda T. Isolation and identification of 24,25-dihydroxychoelcalciferol: a metabolite of vitamin D3 made in the kidney. Biochemistry. 1972;11:41514255.
  • 53
    Ohyama Y, Noshiro M, Okuda K. Cloning and expression of cDNA encoding 25-hydroxyvitamin D3 24-hydroxylase. FEBS Lett. 1991;2789:195198.
  • 54
    Tanaka Y, DeLuca HF. Stimulation of 24,25-dihydroxyvitamin D3 production by 1,25-dihydroxyvitamin D3. Science. 1974;183:11981200.
  • 55
    Zierold C, Darwish HM, DeLuca HF. Two vitamin response elements function in the rat 1,25-dihydroxyvitamin D 24-hydroxylase promoter. J Biol Chem. 1995;270:16751678.
  • 56
    Beckman MJ, Tadikona P, Werner E, Prahl J, Yamada S, DeLuca HF. The human 25-hydroxyvitamin D3-24-hydroxylase, a multicatalytic enzyme. Biochemistry. 1996;35:84658472.
  • 57
    Akiyoshi-Shibata M, Sakaki T, Ohyama Y, Noshiro M, Okuda K, Yabusaki Y. Further oxidation of hydroxycalcidiol by calcidiol 24-hydroxylase. A study with the mature enzyme expressed in Escherichia coli. Eur J Biochem. 1994;224:335343.
  • 58
    Onisko BL, Esvelt RP, Schnoes HK, DeLuca HF. Metabolites of 1α,25-dihydroxyvitamin D3 in rat bile. Biochemistry. 1980;19:41244130.
  • 59
    St-Arnaud R, Arabian A, Travers R, et al. Deficient mineralization of intramembranous bone in vitamin D-24-hydroxylase-ablated mice is due to elevated 1,25-dihydroxyvitamin D and not to the absence of 24,25-dihydroxyvitamin D. Endocrinology. 2000;141:26582666.
  • 60
    Endres B, Kato S, DeLuca HF. Metabolism of 1α,25-dihydroxyvitamin D3 in vitamin D receptor ablated mice in vivo. Biochemistry. 2000;39:21232129.
  • 61
    Baker AR, McDonnell DP, Hughes M, et al. Cloning and expression of full-length cDNA encoding human vitamin D receptor. Proc Natl Acad Sci USA. 1988;85:32943298.
  • 62
    Burmester JK, Maeda N, DeLuca HF. Isolation and expression of rat 1,25-dihydroxyvitamin D3 receptor cDNA. Proc Natl Acad Sci USA. 1988;85:10051009.
  • 63
    Munder M, Herzberg IM, Zierold C, et al. Identification of the porcine intestinal accessory factor that enables DNA sequence recognition by vitamin D receptor. Proc Natl Acad Sci USA. 1995;93:27962799.
  • 64
    Kliewer SA, Umesono K, Mangelsdorf DJ, Evans RM. Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signaling. Nature. 1991;355:446449.
  • 65
    Umesono K, Murakami KK, Thompson CC, Evans RM. Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors. Cell. 1991;65:12551266.
  • 66
    Brooks MH, Bell NH, Love L, et al. D-dependent rickets type II. Resistance of target organs to 1,25-dihydroxyvitamin D. New Eng. J Med. 1978;298:996999.
  • 67
    Balsan S, Garabedian M, Liberman UA, et al. Rickets and alopecia with resistance to 1,25-dihydroxyvitmain D: two different clinical courses with two different cellular defects. J Clin Endocrinol Metab. 1983;57:803811.
  • 68
    Yoshizawa T, Handa Y, Uematsu Y, et al. Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nat Genet. 1997;16:391396.
  • 69
    Li YC, Pirro AE, Amling M, et al. Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia. Proc Natl Acad Sci USA. 1997;94:98319835.
  • 70
    Johnson LE, DeLuca HF. Reproductive defects are corrected in vitamin D-deficient female rats when fed a high calcium, phosphorus, and lactose diet. J Nutr. 2002;132:22702273.
  • 71
    Demay MB. Mouse models of vitamin D receptor ablation. In: FeldmanD, PikeJW, GlorieuxFH, eds. Vitamin D, 2nd edn. San Diego, CA: Elsevier Academic Press; 2005:341349.
  • 72
    Johnson LE, DeLuca HF. Vitamin D receptor null mutant mice fed high levels of calcium are fertile. J Nutr. 2001;131:17871791.
  • 73
    Norman AW. 1α,25(OH)2-Vitamin D3-mediated rapid and genomic responses are dependent upon critical structure – function relationships for both the ligand and receptor(s). In: FeldmanD, PikeJW, GlorieuxFH, eds. Vitamin D, 2nd edn. San Diego, CA: Elsevier Academic Press; 2005:381407.
  • 74
    Dowd D, Sutton ALM, Zhang C, MacDonald PN. Comodulators of vitamin D receptor-mediated gene expression. In: FeldmanD, PikeJW, GlorieuxFH, eds. Vitamin D, 2nd edn. San Diego, CA: Elsevier Academic Press; 2005:291304.
  • 75
    Kimmel-Jehan C, Darwish HM, Strugnell SA, Jehan F, Wiefling B, DeLuca HF. DNA bending is induced by binding of vitamin D receptor-retinoid X receptor heterodimers to vitamin D response elements. J Cell Biochem. 1999;74:220228.
  • 76
    Hilliard GM IV, Cook RG, Weigel NL, Pike JW. 1,25-Dihydroxyvitamin D3 modulates phosphorylation of serine 205 in the human vitamin D receptor: site-directed mutagenesis of this residue promotes alternative phosphorylation. Biochemistry. 1994;33:43004311.
  • 77
    Zella LA, Kim S, Shevde NK, Pike JW. Enhancers located in the vitamin D receptor gene mediate transcriptional autoregulation by 1,25-dihydroxyvitamin D3. J Ster Biochem Mol Biol. 2007;103:435439.
  • 78
    Kutuzova GD, DeLuca HF. Gene expression profiles in rat intestine identify pathways for 1,25-dihydroxyvitamin D3 stimulated calcium absorption and clarify its immunomodulatory properties. Arch Biochem Biophys. 2004;432:152166.
  • 79
    Esteban LM, Eisman J, Gardiner EM. Vitamin D receptor promoter and regulation of receptor expression. Chapter 12. In: FeldmanD, PikeJW, GlorieuxFH, eds. Vitamin D, 2nd edn. San Diego, CA: Elsevier Academic Press; 2005:193217.
  • 80
    Jehan F, DeLuca HF. Cloning and characterization of the mouse vitamin D receptor promoter. Proc Natl Acad Sci USA. 1997;94:1013810143.
  • 81
    Sandgren ME, Brönnegärd M, DeLuca HF. Tissue distribution of the 1,25-dihydroxyvitamin D3 receptor in the male rat. Biochem Biophys Res Commun. 1991;181:611616.
  • 82
    Healy KD, Zella JB, Prahl JM, DeLuca HF. Regulation of the murine renal vitamin D receptor by 1,25-dihydroxyvitamin D3 and calcium. Proc Natl Acad Sci USA. 2003;100:97339737.
  • 83
    Dame MC, Pierce EA, Prahl JM, Hayes CE, DeLuca HF. Monoclonal antibodies to the porcine intestinal receptor for 1,25-dihdyroxyvitamin D3: interaction with distinct receptor domains. Biochemistry. 1986;25:45234534.
  • 84
    Brown AJ, Slatopolsky E. Drug insight: vitamin D analogs in the treatment of secondary hyperparathyroidism in patients with chronic kidney disease. Nat Clin Pract Endocrinol Metab. 2007;3:134144.
  • 85
    Nicolaysen R. Studies upon the mode of action of vitamin D. III. The influence of vitamin D on the absorption of calcium and phosphorus in the rat. Biochem J. 1937;31:122129.
  • 86
    Wasserman RH. Vitamin D and the intestinal absorption of calcium: a view and overview. Chapter 24. In: FeldmanD, PikeJW, GlorieuxFH, eds. Vitamin D, 2nd edn. San Diego, CA: Elsevier Academic Press; 2005:411428.
  • 87
    Dowdle EB, Schachter D, Schenker H. Requirement for vitamin D for the active transport of calcium by the intestine. Am J Physiol. 1960;198:269274.
  • 88
    Brautbar N, Levine BS, Walling MW, Coburn JW. Intestinal absorption of calcium: role of dietary phosphate and vitamin D. Am J Physiol. 1981;241:G49G53.
  • 89
    Wasserman RH, Feher JJ. Vitamin D-dependent calcium-binding proteins. In: WassermanRH, CorradinoRA, CarafoliE, KretsingerRH, MacLennanDH, SiegelFL, eds. Calcium-Binding Proteins and Calcium Function. New York: Elsevier; 1977:293302.
  • 90
    Hoenderop JG, Nilius B, Bindels RJ. Calcium absorption across epithelia. Physiol Rev. 2005;85:373422.
  • 91
    Kutuzova GD, Akhter S, Christakos S, Vanhooke J, Kimmel-Jehan C, DeLuca HF. Calbindin D9k knockout mice are indistinguishable from wild-type mice in phenotype and serum calcium level. Proc Natl Acad Sci USA. 2006;103:1237712381.
  • 92
    Akhter S, Kutuzova GC, Christakos S, DeLuca HF. Calbindin D9k is not required for 1,25-dihydroxyvitamin D3-mediated Ca2+ absorption in small intestine. Arch Biochem Biophys. 2007;460:227232.
  • 93
    Benn BS, Peng X, Dhawan P, et al. Studies using null mutant mice reveal active intestinal calcium transport in the absence of calbindin-D9k or TRPV6. 2006 ASBMR Abstract. Presentation11: Young Investigator Award.
  • 94
    Barthel TK, Mathern DR, Whitfield GK, et al. 1,25-Dihydroxyvitamin D3/VDR-mediated induction of FGF23 as well as transcriptional control of other bone anabolic and catabolic genes that orchestrate the regulation of phosphate and calcium mineral metabolism. J Steroid Biochem Mol Biol. 2007;103:381388.
  • 95
    Slatopolsky E, Brown A, Dusso A. Calcium, phosphorus and vitamin D disorders in uremia. Contrib Nephrol. 2005;149:262271.
  • 96
    Lam HY, Schnoes HK, DeLuca HF. Synthesis of 1α-hydroxyergocalciferol. Steroids. 1977;30:671177.
  • 97
    Thadhani R, Wolf M. Vitamin D in patients with kidney disease: cautiously optimistic. Adv Chronic Kidney Dis. 2007;14:2226.
  • 98
    Plum LA, Prahl JM, Ma X, et al. Biologically active non-calcemic analogs of 1α,25-dihydroxyvitamin D with an abbreviated side chain containing no hydroxyl. Proc Natl Acad Sci USA. 2004;101:69006904.
  • 99
    Slatoplosky E, Finch JL, Brown AJ, et al. Effect of 2-methylene-19-nor-(20S)-1α-hydroxy-bishomopregnacalciferol (2MbisP), an analog of vitamin D, on secondary hyperparathyroidism. J Bone Miner Res. 2007;22:686694.
  • 100
    Abe E, Miura C, Sakagami H, et al. Differentiation of mouse myeloid leukemia cells induced by 1α,25-dihydroxyvitamin D3. Proc Natl Acad Sci USA. 1981;78:49904994.
  • 101
    Tanaka H, Abe E, Miyaura C, et al. 1α,25-Dihydroxycholecalciferol and a human myeloid leukemia cell line (HL-60). The presence of a cytosol receptor and induction of differentiation. Biochem J. 1982;204:713719.
  • 102
    Wilson AJ, Velcich A, Arango D, et al. Novel detection and differential utilization of a c-myc transcriptional block in colon cancer chemoprevention. Cancer Res. 2002;62:60066010.
  • 103
    Eisman JA, Koga M, Sutherland RL, Barkla DH, Tutton PJM. 1,25-Dihydroxyvitamin D3 and the regulation of human cancer cell replication. Proc Soc Exp Biol Med. 1989;191:221226.
  • 104
    Binderup L, Bramm E. Effects of a novel vitamin D analogue MC 903 on cell proliferation and differentiation in vitro and on calcium metabolism in vivo. Biochem Pharmacol. 1988;37:889895.
  • 105
    Yasuda H, Kigashio K, Suda T. Vitamin D and osteoclastogenesis. In: FeldmanD, PikeJW, GlorieuxFH, eds. Vitamin D, 2nd edn. San Diego, CA: Elsevier Academic Press; 2005:665685.
  • 106
    Yang S, Smith C, Prahl JM, DeLuca HF. Vitamin D deficiency suppresses cell-mediated immunity in vivo. Arch Biochem Biophys. 1993;303:98106.
  • 107
    Cantorna MT, Hayes CE, DeLuca HF. 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc Natl Acad Sci USA. 1996;93:78617864.
  • 108
    Cantorna MT, Hayes CE, DeLuca HF. 1,25-Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis. J Nutr. 1998;128:6872.
  • 109
    Zella JB, McCary LC, DeLuca HF. Oral administration of 1,25-dihydroxyvitamin D3 completely protects NOD mice from insulin-dependent diabetes mellitus. Arch Biochem Biophys. 2003;417:7780.
  • 110
    Cantorna MT. Vitamin D and its role in immunology: multiple sclerosis, and inflammatory bowel disease. Prog Biophys Mol Biol. 2006;92:6064.
  • 111
    Xue Y, Karaplis AC, Hendy GN, Goltzman D, Miao D. Exogenous 1,25-dihydroxyvitamin D3 exerts a skeletal anabolic effect and improve mineral ion homeostasis in mice that are homozygous for both the 1α-hydroxylase and parathyroid hormone null alleles. Endocrinology. 2006;147:48014810.
  • 112
    Sicinski JRR, Prahl JM, Smith CM, DeLuca HF. New 1α,25-dihydroxy-19-norvitamin D3 compounds of high biological activity: synthesis and biological evaluation of 2-hydroxymethyl, 2-methyl and 2-methylene analogs. J Med Chem. 1998;4:46624674.
  • 113
    Shevde NK, Plum LA, Clagett-Dame M, Yamamoto H, Pike JW, DeLuca HF. A novel potent analog of 1α,25-dihydroxyvitamin D3 selectively induces bone formation. Proc Natl Acad Sci USA. 2002;99:1348713491.
  • 114
    Plum LA, Fitzpatrick LA, Ma X, et al. 2MD, a new anabolic agent for osteoporosis treatment. Osteoporosis Int. 2006;17:704715.
  • 115
    Ke HZ, Zi H, Crawford DT, et al. A new vitamin D analog, 2MD, restores trabecular and cortical bone mass and strength in ovariectomized rats with established osteopenia. J Bone Miner Res. 2005;20:17421755.
  • 116
    Zella LA, Shevde NK, Hollis BW, Cooke NE, Pike JW. Vitamin D-binding protein influences total circulating levels of 1,25-dihydroxyvitamin D3 but does not directly modulate the bioactive levels of the hormone in vivo. Endocrinology. 2008;149:36563667.
  • 117
    Safadi FF, Thornton P, Magiera H, et al. Osteopathy and resistance to vitamin D toxicity in mice null for vitamin D binding protein. J Clin Invest. 1999;103:239251.
  • 118
    Peleg S, Sastry M, Collins ED, Bishop JW, Norman AW. Distinct conformational changes induced by 20-epi analogs of 1,25-dihdyroxyvitamin D3 are associated with enhanced activation of the vitamin D receptor. J Biol Chem. 1995;270:1055110558.
  • 119
    Rochel N, Wurtz JM, Mitschler A, Klaholz B, Moras D. The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand. Molec Cell. 2000;5:173179.
  • 120
    Vanhooke JL, Benning MM, Bauer CB, Pike JW, DeLuca HF. Molecular structure of the rat vitamin D receptor ligand binding domain complexed with 2-carbon-substituted vitamin D3 hormone analogues and a LXXLL-containing coactivator peptide. Biochemistry. 2004;43:41044110.
  • 121
    Rochel N, Hourai S, Perez-Garcia X, Rumbo A, Mourino A, Moras D. Crystal structure of the vitamin D nuclear receptor ligand binding domain in complex with a locked side chain analog of calcitriol. Arch Biochem Biophys. 2007;460:172176.